Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: An in vitro study

Neurosurgery

Volumn 59, Issue 6, 2006, Pages 1313-1323

  Colen, Chaim B ^a   Seraji Bozorgzad, Navid ^a   Marples, Brian ^a   Galloway, Matthew P ^a   Sloan, Andrew E ^b   Mathupala, Saroj P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

cyano 4 hydroxycinnamic acid; Glioma therapy; Lactate; Magnetic resonance spectroscopy; Tumor metabolism

Indexed keywords

ALANINE; ALPHA CYANO 4 HYDROXYCINNAMIC ACID; CHOLINE; FLUORESCEIN ISOTHIOCYANATE; GLUTAMIC ACID; GLUTATHIONE; GLYCINE; LACTIC ACID; PHOSPHORYLCHOLINE; TAURINE;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CELL DEATH; CELL VIABILITY; CLONOGENIC ASSAY; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOBLASTOMA; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LETHAL DOSE; LOW ENERGY RADIATION; MITOCHONDRIAL ENERGY TRANSFER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOSENSITIZATION;

ADAPTATION, PHYSIOLOGICAL; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COUMARIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOMA; HUMANS; LACTIC ACID; NEOPLASM PROTEINS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; SIGNAL TRANSDUCTION;

EID: 33845641599     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000249218.65332.BF     Document Type: Article

References (40)

1. Ahmad IM, Aykin-Burns N, Sim JE, Walsh SA, Higashikubo R, Buettner GR, Venkataraman S, Mackey MA, Flanagan SW, Oberley LW, Spitz DR: Mitochondrial O2*- and H2O2 mediate glucose deprivation-induced stress in human cancer cells. J Biol Chem 280:4254-4263, 2005.
2. Baggetto LG: Deviant energetic metabolism of glycolytic cancer cells. Biochimie 74:959-974, 1992.
3. Beauchesne PD, Bertrand S, Branche R, Linke SP, Revel R, Dore JF, Pedeux RM: Human alignant glioma cell lines are sensitive to low radiation doses. Int J Cancer 105:33-40, 2003.
4. Berg JM, Tymoczko JL, Stryer L: Biochemistry. New York, W.H. Freeman, 2002.
5. Brand K: Aerobic glycolysis by proliferating cells: Protection against oxidative stress at the expense of energy yield. J Bioenerg Biomembr 29:355-364, 1997.
6. Chalmers A, Johnston P, Woodcock M, Joiner M, Marples B: PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation. Int J Radiat Oncol Biol Phys 58:410-419, 2004.
7. Cheng LL, Ma MJ, Becerra L, Ptak T, Tracey I, Lackner A, Gonzalez RG: Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 94:6408-6413, 1997.
8. Delbeke D, Martin WH: Metabolic imaging with FDG: A primer. Cancer J 10:201-213, 2004.
9. Estrela JM, Ortega A, Obrador E: Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43:143-181, 2006.
10. Fiveash JB, Spencer SA: Role of radiation therapy and radiosurgery in glioblastoma multiforme. Cancer J 9:222-229, 2003.
11. Gillies RJ, Morse DL: In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng 7:287-326, 2005.
12. Gupta RC, Win T, Bittner S: Taurine analogues; a new class of therapeutics: Retrospect and prospects. Curr Med Chem 12:2021-2039, 2005.
13. Halestrap AP, Denton RM: Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by alpha-cyano-4-hydroxy-cinnamate. Biochem J 138:313-316, 1974.
14. Halestrap AP, Meredith D: The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447:619-628, 2004.
15. Halestrap AP, Price NT: The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation. Biochem J 343:281-299, 1999.
16. Inoue M, Sato EF, Nishikawa M, Park AM, Kira Y, Imada I, Utsumi K: Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem 10:2495-2505, 2003.
17. Joiner MC, Marples B, Lambin P, Short SC, Turesson I: Low-dose hypersensitivity: Current status and possible mechanisms. Int J Radiat Oncol Biol Phys 49:379-389, 2001.
18. Kasischke KA, Vishwasrao HD, Fisher PJ, Zipfel WR, Webb WW: Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 305:99-103, 2004.
19. Kirsch M, De Groot H: NAD(P)H, a directly operating antioxidant? FASEB J 15:1569-1574, 2001.
20. Lafleur MV, Woldhuis J, Loman H: Effects of sulphydryl compounds on the radiation damage in biologically active DNA. Int J Radiat Biol Relat Stud Phys Chem Med 37:493-498, 1980.
21. Laperriere N, Zuraw L, Cairncross G; Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group: Radiotherapy for newly diagnosed malignant glioma in adults: Asystematic review. Radiother Oncol 64:259-273, 2002.
22. Marples B: Is low-dose hyper-radiosensitivity a measure of G2-phase cell radiosensitivity? Cancer Metastasis Rev 23:197-207, 2004.
23. Marples B, Cann NE, Mitchell CR, Johnston PJ, Joiner MC: Evidence for the involvement of DNA-dependent protein kinase in the phenomena of low dose hyper-radiosensitivity and increased radioresistance. Int J Radiat Biol 78:1139-1147, 2002.
24. Marples B, Joiner MC: The response of Chinese hamster V79 cells to low radiation doses: Evidence of enhanced sensitivity of the whole cell population. Radiat Res 133:41-51, 1993.
25. Marples B, Wouters BG, Collis SJ, Chalmers AJ, Joiner MC: Low-dose hyper-radiosensitivity: A consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat Res 161:247-255, 2004.
26. Mathupala SP, Parajuli P, Sloan AE: Silencing of monocarboxylate transporters via small interfering ribonucleic acid inhibits glycolysis and induces cell death in malignant glioma: An in vitro study. Neurosurgery 55: 1410-1419, 2004.
27. Mathupala SP, Rempel A, Pedersen PL: Aberrant glycolytic metabolism of cancer cells: A remarkable coordination of genetic, transcriptional, posttranslational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr 29:339-343, 1997.
28. Matsutani M: Chemoradiotherapy for brain tumors: Current status and perspectives. Int J Clin Oncol 9:471-474, 2004.
29. Mornex F, Nayel H, Taillandier L: Radiation therapy for malignant astrocytomas in adults. Radiother Oncol 27:181-192, 1993.
30. Pedersen PL: Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res 22:190-274, 1978.
31. Provencher SW: LCModel Manual. http://s-provencher.com/pages/lcm-manual. shtml. Accessed 12/12/05.
32. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679, 1993.
33. Robson T, Worthington J, McKeown SR, Hirst DG: Radiogenic therapy: Novel approaches for enhancing tumor radiosensitivity. Technol Cancer Res Treat 4:343-361, 2005.
34. Roslin M, Henriksson R, Bergstrom P, Ungerstedt U, Bergenheim AT: Baseline levels of glucose metabolites, glutamate and glycerol in malignant glioma assessed by stereotactic microdialysis. J Neurooncol 61:151-160, 2003.
35. Shimizu T, Iwanaga M, Yasunaga A, Urata Y, Goto S, Shibata S, Kondo T: Protective role of glutathione synthesis on radiation-induced DNA damage in rabbit brain. Cell Mol Neurobiol 18:299-310, 1998.
36. Spencer TL, Lehninger AL: L-lactate transport in Ehrlich ascites-tumour cells. Biochem J 154:405-414, 1976.
37. Venkatachalam SR, Chattopadhyay S: Natural radioprotective agents: An overview. Curr Org Chem 9:389-404, 2005.
38. Volk C, Kempski B, Kempski OS: Inhibition of lactate export by quercetin acidifies rat glial cells in vitro. Neurosci Lett 223:121-124, 1997.
39. Warburg O, Dickens F, Kaiser Wilhelm-Institut für Biologie: The Metabolism of Tumours: Investigations from the Kaiser-Wilhelm Institute for Biology, Berlin-Dahlem. London, Constable, 1930.
40. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W: Sublethal irradiation promotes migration and invasiveness of glioma cells: Implications for radiotherapy of human glioblastoma. Cancer Res 61:2744-2750, 2001.